Oxford Immunotec Global PLC Ordinary Shares
OXFD
OXFD was delisted on the 5th of March, 2021.
61 hedge funds and large institutions have $251M invested in Oxford Immunotec Global PLC Ordinary Shares in 2015 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 35 increasing their positions, 11 reducing their positions, and 4 closing their positions.
218% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 11
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
5% more funds holding
Funds holding: 58 → 61 (+3)
1% more capital invested
Capital invested by funds: $249M → $251M (+$1.65M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
+$5.94M |
| 2 |
PC
Polar Capital
London,
United Kingdom
|
+$5M |
| 3 |
Axa
Paris,
France
|
+$1.85M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$872K |
| 5 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
+$730K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$4.76M |
| 2 |
CV
Clarus Ventures
Cambridge,
Massachusetts
|
-$2.76M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$2.74M |
| 4 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
-$1.58M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$482K |
OXFD Hedge Fund Activity: Q2 2015 in Review
61 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q2 2015, worth a combined $251M — up 0.66% from $249M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new OXFD positions and 4 closed out — a net gain of 3 holders — while 35 added to existing stakes and 11 trimmed.
The largest buyer was OppenheimerFunds, adding an estimated $5.94M. The largest seller was Wells Fargo, cutting an estimated $4.76M.
- 61 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q2 2015, up from 58 in Q1 2015.
- Funds reported $251M of Oxford Immunotec Global PLC Ordinary Shares stock for Q2 2015, up 0.66% quarter-over-quarter.
- 7 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q2 2015 and 4 closed out, a net change of +3 holders.
- The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q2 2015 was OppenheimerFunds, an estimated $5.94M added.
- The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q2 2015 was Wells Fargo, an estimated $4.76M sold.
Based on aggregated 13F filings for Q2 2015.